Invesco’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$39.9M Sell
721,680
-137,968
-16% -$7.63M 0.01% 1151
2025
Q1
$41.6M Buy
859,648
+120,696
+16% +$5.84M 0.01% 1109
2024
Q4
$28.5M Buy
738,952
+85,800
+13% +$3.31M 0.01% 1319
2024
Q3
$29.4M Buy
653,152
+564,718
+639% +$25.4M 0.01% 1284
2024
Q2
$3.06M Buy
88,434
+60,075
+212% +$2.08M ﹤0.01% 2407
2024
Q1
$820K Sell
28,359
-17,404
-38% -$503K ﹤0.01% 3076
2023
Q4
$1.05M Buy
45,763
+4,862
+12% +$111K ﹤0.01% 2860
2023
Q3
$682K Sell
40,901
-223,510
-85% -$3.73M ﹤0.01% 3036
2023
Q2
$7.3M Sell
264,411
-13,525
-5% -$374K ﹤0.01% 2022
2023
Q1
$6.39M Buy
277,936
+246,384
+781% +$5.67M ﹤0.01% 2092
2022
Q4
$344K Buy
31,552
+2,828
+10% +$30.9K ﹤0.01% 3429
2022
Q3
$242K Sell
28,724
-779
-3% -$6.56K ﹤0.01% 3589
2022
Q2
$233K Sell
29,503
-523
-2% -$4.13K ﹤0.01% 3647
2022
Q1
$711K Buy
30,026
+10,201
+51% +$242K ﹤0.01% 3203
2021
Q4
$678K Sell
19,825
-2,627
-12% -$89.8K ﹤0.01% 3222
2021
Q3
$398K Buy
22,452
+4,330
+24% +$76.8K ﹤0.01% 3502
2021
Q2
$814K Buy
18,122
+8,019
+79% +$360K ﹤0.01% 3190
2021
Q1
$262K Buy
+10,103
New +$262K ﹤0.01% 3574
2020
Q4
Sell
-189,232
Closed -$3.7M 3777
2020
Q3
$3.7M Sell
189,232
-45,049
-19% -$881K ﹤0.01% 2145
2020
Q2
$4.14M Buy
234,281
+149,351
+176% +$2.64M ﹤0.01% 2087
2020
Q1
$599K Buy
+84,930
New +$599K ﹤0.01% 2963
2019
Q4
Sell
-63,653
Closed -$764K 3631
2019
Q3
$764K Sell
63,653
-21,196
-25% -$254K ﹤0.01% 3089
2019
Q2
$1.03M Buy
84,849
+13,536
+19% +$164K ﹤0.01% 3038
2019
Q1
$896K Buy
+71,313
New +$896K ﹤0.01% 3063
2018
Q3
Sell
-72,964
Closed -$490K 3861
2018
Q2
$490K Buy
72,964
+16,656
+30% +$112K ﹤0.01% 3422
2018
Q1
$484K Buy
+56,308
New +$484K ﹤0.01% 3339